Advertisement

Screening Mammography: Update and Review of Publications Since Our Report in the New England Journal of Medicine on the Magnitude of the Problem in the United States

Published:November 05, 2015DOI:https://doi.org/10.1016/j.acra.2015.10.002
      Because the four letters of correspondence describe a variety of concerns, I have organized them according to their general topic and in some instances re-emphasized data from the original reports (
      • Bleyer A.
      • Welch H.G.
      Effect of three decades of screening mammography on the incidence of breast cancer.
      ,
      • Bleyer A.
      Were our estimates of overdiagnosis with mammography screening in the United States “based on faulty science?”.
      ,
      • Bleyer A.
      Screening mammography: update and review of publications since our report in the New England Journal of Medicine on the magnitude of the problem in the United States.
      ).
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Academic Radiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bleyer A.
        • Welch H.G.
        Effect of three decades of screening mammography on the incidence of breast cancer.
        NEJM. 2012; 367: 1998-2005
        • Bleyer A.
        Were our estimates of overdiagnosis with mammography screening in the United States “based on faulty science?”.
        Oncologist. 2014; 19: 113-126
        • Bleyer A.
        Screening mammography: update and review of publications since our report in the New England Journal of Medicine on the magnitude of the problem in the United States.
        Acad Radiol. 2015; 22: 949-960
        • Helvie M.A.
        • Chang J.T.
        • Hendrick R.E.
        Reply to flawed assumptions used to defend screening mammography.
        Cancer. 2015; 121: 321-323
        • Heston J.F.
        • Cusano M.M.
        • Young J.L.
        • et al.
        Forty-five years of cancer incidence in Connecticut: 1935–1979.
        Natl Cancer Inst Monogr. 1986; 70: 1-706
        • Howard J.
        Using mammography for cancer control: an unrealized potential.
        CA Cancer J Clin. 1987; 37: 33-48
        • Shapiro S.
        The status of breast cancer screening: a quarter of a century of research.
        World J Surg. 1989; 13: 9-18
        • Devesa S.S.
        • Silverman D.T.
        • Young J.L.
        • et al.
        Cancer incidence and mortality trends among whites in the United States, 1947-84.
        J Natl Cancer Inst. 1987; 79: 701-770
        • Christiansen P.
        • Vejborg I.
        • Kroman N.
        • et al.
        Position paper: breast cancer screening, diagnosis, and treatment in Denmark.
        Acta Oncol. 2014; 53: 433-444
        • Sigurdsson K.
        • Olafsdottir E.J.
        Population-based service mammography screening: the Icelandic experience.
        Breast Cancer (Dove Med Press). 2013; 5: 17
      1. Demographics of Iceland.
        (Available at:) (Accessed August 3, 2015)
        • Cronin K.A.
        • Feuer E.J.
        • Clarke L.D.
        • et al.
        Impact of adjuvant therapy and mammography on U.S. mortality from 1975 to 2000: comparison of mortality results from the CISNET breast cancer base case analysis.
        J Natl Cancer Inst Monogr. 2006; : 112-121
        • Yankaskas B.C.
        Epidemiology of breast cancer in young women.
        Breast Dis. 2005-2006; 23: 3-8
        • Collaborative Group on Hormonal Factors in Breast Cancer
        Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease.
        Lancet. 2002; 360: 187-195
        • Helewa M.
        • Lévesque P.
        • Provencher D.
        • et al.
        Breast cancer, pregnancy, and breastfeeding.
        J Obstet Gynaecol Can. 2002; 24: 164-180
        • Etzioni R.
        • Xia J.
        • Hubbard R.
        • et al.
        A reality check for overdiagnosis estimates associated with breast cancer screening.
        J Natl Cancer Inst. 2014; 106
        • Baker S.G.
        • Prorok C.
        • Kramer B.S.
        Lead time and overdiagnosis.
        J Natl Cancer Inst. 2014; 106: dju346https://doi.org/10.1093/jnci/dju346
      2. Use of mammography among women 40 years of age and over, by selected characteristics: United States, selected years 1987–2008.
        (Table 86 (page 1 of 3). Atlanta: Centers for Disease Control and Prevention. Available at:) (Accessed August 4, 2015)
      3. Breast Cancer Surveillance Consortium mammography data.
        (Available at:) (Accessed August 4, 2015)
        • Seidenwurm D.
        Counterpoint: the New England Journal of Medicine article suggesting overdiagnosis from mammography screening is scientifically correct and should not be withdrawn.
        J Am Coll Radiol. 2013; 10: 320-323
      4. Surveillance, Epidemiology, and End Results (SEER) Program.
        (SEER*Stat Database: Incidence—SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2014 Sub (1973-2012 varying)—Linked To County Attributes—Total U.S., 1969-2013 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2015, based on the November 2014 submission. Available at:) (Accessed August 4, 2015)
        • Brodersen J.
        • Jørgensen K.J.
        The balance is shifting away from screening.
        Clin Adv Hematol Oncol. 2014; 12: 407-409
        • Harding C.
        • Pompei F.
        • Burmistrov D.
        • et al.
        Breast cancer screening, incidence, and mortality across U.S. counties.
        JAMA Intern Med. 2015; 175 (Published online July 6, 2015): 1483-1489
      5. Appendix of randomized controlled trials.
        (Available at) (Accessed August 4, 2015)
        • Miller A.B.
        • Wall C.
        • Baines C.J.
        • et al.
        Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial.
        BMJ. 2014; 348: g366
        • Gøtzsche P.C.
        • Nielsen M.
        Screening for breast cancer with mammography (Review).
        Cochrane Database Syst Rev. 2011; (CD001877)
        • Marmot M.G.
        Sorting through the arguments on breast screening.
        JAMA. 2013; 309: 2553-2554
        • Newman D.H.
        Screening for breast and prostate cancers. Moving toward transparency.
        J Natl Cancer Inst. 2010; 102: 1008-1011
      6. Breast cancer screening for health professionals: Benefits of screening: Randomized controlled trials; Summary.
        (Available at:) (Accessed August 4, 2015)
        • Walter L.C.
        • Schonberg M.A.
        Screening mammography in older women: a review.
        JAMA. 2014; 311: 1336-1347
        • Lee S.J.
        • Boscardin W.J.
        • Stijacic-Cenzer I.
        • et al.
        Time lag to benefit after screening for breast and colorectal cancer: meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark.
        BMJ. 2013; 346: e8441
        • Osler W.
        The medical aspects of carcinoma of the breast, with a note on the spontaneous disappearance of secondary growths.
        Amer Med Phila. 1901; 17: 63-66
        • Osler W.
        An address on the medical aspects of carcinoma of the breast.
        Br Med J. 1906; 1: 1-4
        • Rohdenburg G.L.
        Fluctuations in the growth energy of tumors in man, with special reference to spontaneous recession.
        J Cancer Res. 1918; 3: 193-225
        • Fauvet J.
        • Roujeau J.
        • Piet R.
        Spontaneous cancer cures and regressions.
        Rev Prat. 1964; 14 (in French): 2177-2180
        • Challis G.B.
        • Stam H.J.
        The spontaneous regression of cancer. A review of cases from 1900 to 1987.
        Acta Oncol. 1990; 29: 545-550
        • Nielsen M.
        • Thomsen J.L.
        • Primdahl S.
        • et al.
        Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies.
        Br J Cancer. 1987; 56: 814-819
      7. Cancer Query System: probability of developing or dying of cancer.
        (Available at:) (Accessed August 3, 2015)
        • Bhathal P.S.
        • Brown R.W.
        • Lesueur G.C.
        • et al.
        Frequency of benign and malignant breast lesions in 207 consecutive autopsies in Australian women.
        Br J Cancer. 1985; 51: 271-278
        • Alpers C.E.
        • Wellings S.R.
        The prevalence of carcinoma in situ in normal and cancer-associated breasts.
        Hum Pathol. 1985; 16: 796-807
      8. Breast screening: helping you decide.
        (National Health Service. NHS Cancer Screening Programmes 2901195, pp. 9–11. Available at:) (Accessed August 4, 2015)
        • Research Council of Norway
        Research-based evaluation of the Norwegian Breast Cancer Screening Program Final report.
        (The Research Council of Norway, Oslo, May; p. 9. Available at:) (Accessed August 4, 2015)
        • Woods W.G.
        Substitute “prostate cancer” for “neuroblastoma?”.
        J Clin Oncol. 2002; 20: 1154-1155
        • Patz E.F.
        • Pinsky P.
        • Gatsonis C.
        • et al.
        Overdiagnosis in low-dose computed tomography screening for lung cancer.
        JAMA Intern Med. 2014; 174: 269-274
        • Weyers W.
        The “epidemic” of melanoma between under- and overdiagnosis.
        J Cutan Pathol. 2012; 39: 9-16
        • Spix C.
        • Michaelis J.
        • Berthold F.
        • et al.
        Lead-time and overdiagnosis estimation in neuroblastoma screening.
        Stat Med. 2003; 22: 2877-2892
        • Loeb S.
        • Bjurlin M.A.
        • Nicholson J.
        • et al.
        Overdiagnosis and overtreatment of prostate cancer.
        Eur Urol. 2014; 65: 1046-1055
        • O'Grady T.J.
        • Gates M.A.
        • Boscoe F.P.
        Thyroid cancer incidence attributable to overdiagnosis in the United States 1981-2011.
        Int J Cancer. 2015; 137: 2664-2673